MADEDDU, GIORDANO
 Distribuzione geografica
Continente #
NA - Nord America 150
AS - Asia 107
EU - Europa 79
SA - Sud America 38
AF - Africa 1
OC - Oceania 1
Totale 376
Nazione #
US - Stati Uniti d'America 146
SG - Singapore 79
IT - Italia 59
BR - Brasile 37
CN - Cina 7
IN - India 6
DE - Germania 5
HK - Hong Kong 4
FI - Finlandia 3
GB - Regno Unito 3
IQ - Iraq 3
KR - Corea 3
MX - Messico 3
NL - Olanda 3
IE - Irlanda 2
JP - Giappone 2
PL - Polonia 2
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ES - Italia 1
JO - Giordania 1
NP - Nepal 1
VE - Venezuela 1
Totale 376
Città #
Santa Clara 84
Singapore 71
Rende 12
Catania 10
Hefei 7
New York 6
Bologna 4
Boston 4
Hong Kong 4
Kochi 4
Misterbianco 4
São Paulo 4
Ashburn 3
Bastiglia 3
Brooklyn 3
Rome 3
Seoul 3
Atlanta 2
Boardman 2
Chicago 2
Dublin 2
Gütersloh 2
Ipirá 2
Lappeenranta 2
Los Angeles 2
Messina 2
Milan 2
Nova Friburgo 2
Salvador 2
San Francisco 2
San Giovanni la Punta 2
Siena 2
Tokyo 2
Turin 2
Warsaw 2
Abidjan 1
Amman 1
Arcoverde 1
Baghdad 1
Belo Horizonte 1
Castanhal 1
Citrus Heights 1
Ciudad Guayana 1
Conceição do Coité 1
Curitiba 1
Dallas 1
Dhaka 1
Douglasville 1
Downingtown 1
Erbil 1
Flat Rock 1
Florence 1
Glasgow 1
Guadalajara 1
Guarulhos 1
Iporá 1
Joinville 1
Karlsruhe 1
Laguna 1
London 1
Madre de Deus 1
Maringá 1
Mexico City 1
Moreilândia 1
Mucuri 1
Munich 1
Naperville 1
Nepomuceno 1
Newham 1
Nipomo 1
Niterói 1
Nova Serrana 1
Nuremberg 1
Palermo 1
Palmdale 1
Paso Canoas 1
Petrópolis 1
Phoenix 1
Porto Alegre 1
Praia Grande 1
Recife 1
Ribeirão Preto 1
Rio de Janeiro 1
Saint Augustine 1
San Jose 1
Sertanópolis 1
Suzano 1
Sydney 1
São Francisco do Sul 1
São Vicente 1
Thāne 1
Trento 1
Turku 1
Virginia Beach 1
Vitória 1
Zapopan 1
Totale 326
Nome #
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 66
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 33
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 32
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 24
Weight gain: A possible side effect of all antiretrovirals 22
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 22
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 19
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 19
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 17
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 17
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 16
Factors associated with weight gain in people treated with dolutegravir 16
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 14
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort 8
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 8
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 8
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 8
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 8
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 8
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 8
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 7
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: Results of a nationwide cross-sectional study 7
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project) 7
Efficacy of 1998 Vs 2006 first-line antiretroviral regimens for HIV infection: An ordinary clinics retrospective investigation 7
Totale 401
Categoria #
all - tutte 2.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 0 0 0 0 0 0 0 0 3 0 0 0
2023/20242 0 0 0 0 0 1 0 0 0 0 0 1
2024/2025346 8 7 7 7 93 49 3 12 34 41 33 52
2025/202650 50 0 0 0 0 0 0 0 0 0 0 0
Totale 401